91 related articles for article (PubMed ID: 7511810)
1. Rigid-body docking with mutant constraints of influenza hemagglutinin with antibody HC19.
Cherfils J; Bizebard T; Knossow M; Janin J
Proteins; 1994 Jan; 18(1):8-18. PubMed ID: 7511810
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
[TBL] [Abstract][Full Text] [Related]
3. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
4. Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes.
Friedman AR; Roberts VA; Tainer JA
Proteins; 1994 Sep; 20(1):15-24. PubMed ID: 7529922
[TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
Schulze-Gahmen U; Rini JM; Wilson IA
J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
[TBL] [Abstract][Full Text] [Related]
6. Structural evidence for recognition of a single epitope by two distinct antibodies.
Fleury D; Daniels RS; Skehel JJ; Knossow M; Bizebard T
Proteins; 2000 Sep; 40(4):572-8. PubMed ID: 10899782
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment specific for an influenza virus haemagglutinin and of an escape mutant of that haemagglutinin.
Bizebard T; Mauguen Y; Petek F; Rigolet P; Skehel JJ; Knossow M
J Mol Biol; 1990 Dec; 216(3):513-4. PubMed ID: 2258927
[TBL] [Abstract][Full Text] [Related]
8. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
[TBL] [Abstract][Full Text] [Related]
9. Prediction of probable mutations in influenza virus hemagglutinin protein based on large-scale ab initio fragment molecular orbital calculations.
Yoshioka A; Fukuzawa K; Mochizuki Y; Yamashita K; Nakano T; Okiyama Y; Nobusawa E; Nakajima K; Tanaka S
J Mol Graph Model; 2011 Sep; 30():110-9. PubMed ID: 21798776
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody.
Vix O; Rees B; Thierry JC; Altschuh D
Proteins; 1993 Apr; 15(4):339-48. PubMed ID: 8460105
[TBL] [Abstract][Full Text] [Related]
11. Potential of mean force for Syrian hamster prion epitope protein--monoclonal fab 3f4 antibody interaction studies.
Wang YT; Su ZY; Liao JM; Chen CL
Eur J Med Chem; 2009 Sep; 44(9):3504-8. PubMed ID: 19304354
[TBL] [Abstract][Full Text] [Related]
12. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen.
Jackson DC; Brown LE
Pept Res; 1991; 4(3):114-24. PubMed ID: 1823182
[TBL] [Abstract][Full Text] [Related]
15. The 2.5 A resolution structure of the jel42 Fab fragment/HPr complex.
Prasad L; Waygood EB; Lee JS; Delbaere LT
J Mol Biol; 1998 Jul; 280(5):829-45. PubMed ID: 9671553
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.
Ilyushina N; Rudneva I; Gambaryan A; Bovin N; Kaverin N
Virology; 2004 Nov; 329(1):33-9. PubMed ID: 15476872
[TBL] [Abstract][Full Text] [Related]
17. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.
Evans SV; Rose DR; To R; Young NM; Bundle DR
J Mol Biol; 1994 Sep; 241(5):691-705. PubMed ID: 8071993
[TBL] [Abstract][Full Text] [Related]
18. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of GRAMM low-resolution docking methodology on the hemagglutinin-antibody complex.
Vakser IA
Proteins; 1997; Suppl 1():226-30. PubMed ID: 9485517
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of an anticholera toxin peptide complex at 2.3 A.
Shoham M
J Mol Biol; 1993 Aug; 232(4):1169-75. PubMed ID: 7690406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
